ArticleFrontiers in pharmacology2020

Bilirubin Nanoparticles Reduce Diet-Induced Hepatic Steatosis, Improve Fat Utilization, and Increase Plasma β-Hydroxybutyrate.

Terry D Hinds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.